about
Preclinical Development and In Vivo Efficacy of Ceftiofur-PLGA MicroparticlesEvaluation of ceftiofur-PHBV microparticles in rats.Insight into nanoparticle cellular uptake and intracellular targetingBioinformatic detection of E47, E2F1 and SREBP1 transcription factors as potential regulators of genes associated to acquisition of endometrial receptivityA solvent-free thermosponge nanoparticle platform for efficient delivery of labile proteins.Multifunctional polymeric nanoparticles doubly loaded with SPION and ceftiofur retain their physical and biological properties.Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery.Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis.Therapeutic strategies based on polymeric microparticles.Intracellular trafficking and cellular uptake mechanism of PHBV nanoparticles for targeted delivery in epithelial cell lines.Targeted brain delivery nanoparticles for malignant gliomas.Targeted nanoparticles for colorectal cancer.Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells.Mechanistic Studies on the Self-Assembly of PLGA Patchy Particles and Their Potential Applications in Biomedical Imaging.Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles.Bioinspired Heparin Nanosponge Prepared by Photo-crosslinking for Controlled Release of Growth Factors.Atomic-level characterization and cilostazol affinity of poly(lactic acid) nanoparticles conjugated with differentially charged hydrophilic molecules.Drug Delivery Nanocarriers from a Fully Degradable PEG-Conjugated Polyester with a Reduction-Responsive BackboneA novel alendronate functionalized nanoprobe for simple colorimetric detection of cancer-associated hypercalcemiaActive acetylcholine receptors prevent the atrophy of skeletal muscles and favor reinnervation
P50
Q28546727-11213880-DA87-4555-BAEB-D8A1C40CEFDCQ33720030-56F14712-9AAA-40CE-B6E8-BCC80068D838Q34127625-D1E513DA-AB19-481F-95DE-C193644DAC36Q34578834-2FC26542-FC52-4ABE-A3CD-82C4DCFB5DE0Q34579897-B22DB414-EA72-4580-A2D7-C3C518C60FA1Q35102454-08C0BAEB-1047-412D-9610-8B8121F81D8AQ36448811-C78995FB-6D24-4D8F-B270-E3ACEB794420Q37544674-99D5431D-AA7E-4BCE-AEF8-609F15C8C1BBQ38016146-59B1B75D-39FE-4283-A94B-2227FE04ADC3Q38723115-230DED2E-92C5-4D88-8337-5B7236826577Q38791884-88D74FF5-5061-48ED-8C8A-A0D0BA1DFFDEQ42365964-B44F1AFD-1D7E-4725-B83D-2208C775F7BAQ43649190-B958DB43-1191-4F98-9831-DE7F51AFCEB0Q45039136-143F42BF-2832-4302-B415-D946A8686CF6Q45046048-6C20EE3B-F7A1-408D-AFB1-BAB530A4F335Q47165579-E4EF5244-43F2-47A5-9645-C82C00EC801AQ55428121-FEC78B4E-C180-4660-8871-A13ACF0D6E73Q85602682-D146A6E2-D288-41BE-90F1-4335FA8BB2A9Q88770183-C20B391D-500A-493C-83FE-A9B1C04EB3E2Q89900197-1AC6FB65-4956-4EE8-B2D0-031CFCAE0390
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Cristian Vilos
@ast
Cristian Vilos
@en
Cristian Vilos
@es
Cristian Vilos
@sl
type
label
Cristian Vilos
@ast
Cristian Vilos
@en
Cristian Vilos
@es
Cristian Vilos
@sl
altLabel
Cristian Vilos
@en
prefLabel
Cristian Vilos
@ast
Cristian Vilos
@en
Cristian Vilos
@es
Cristian Vilos
@sl
P106
P1153
36873218200
P21
P31
P496
0000-0001-5619-3348